|1.||Pröpper, Kevin: 2 articles (05/2013 - 02/2011)|
|2.||John, Michael: 2 articles (05/2013 - 02/2011)|
|3.||Brückner, Christian: 2 articles (05/2013 - 02/2011)|
|4.||Meyer, Franc: 2 articles (05/2013 - 02/2011)|
|5.||Sarma, H D: 2 articles (10/2012 - 03/2007)|
|6.||Ju, Huangxian: 1 article (07/2015)|
|7.||Liu, Jintong: 1 article (07/2015)|
|8.||Ma, Fengjiao: 1 article (07/2015)|
|9.||Zhang, Lei: 1 article (07/2015)|
|10.||Ling, Pinghua: 1 article (07/2015)|
10/01/2012 - "109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy."
03/01/2007 - "The labeling of a porphyrin, a tumor-avid agent, with a beta-emitting radionuclide for evaluating its potential as an agent for targeted tumor therapy is reported. "
01/01/2009 - "The interaction between cationic porphyrin, a potential valuable anti-tumor and antibiotic drug, and human serum albumin (HSA) was investigated using spectroscopy methods. "
07/11/2015 - "A photosensitized and caspase-responsive multifunctional nanoprobe was designed by assembling a porphyrin, a folate targeting-motif and a dye-labelled peptide in a metal-organic framework (MOF) cage, which significantly increases the singlet oxygen quantum yield of porphyrin by 6.2 times, and achieves high efficient cancer therapy and in situ therapeutic monitoring with caspase-3 activation. "
|2.||Conjoined Twins (Siamese Twins)
|2.||Caspase 3 (Caspase-3)
|6.||Folic Acid (Vitamin M)
|7.||Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)